XDA Developers on MSN

NotebookLM's source limit is its biggest problem

Google, when will you let us have it all?
pharmaphorum

Two of three trials fail, but Sanofi will still file MS drug

Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...